The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 185.00
Bid: 180.00
Ask: 190.00
Change: 2.50 (1.37%)
Spread: 10.00 (5.556%)
Open: 182.50
High: 185.00
Low: 182.50
Prev. Close: 182.50
SNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

6 Jun 2006 07:02

Synexus Clinical Research PLC06 June 2006 Synexus Clinical Research Plc ("the Company") Directorate change Synexus Clinical Research Plc is pleased to announce the appointment of MalcolmHughes (aged 52) as Non-Executive Director with immediate effect. Malcolm is currently Chief Executive of Greenman Group plc ("Greenman"), aprivate industrial company which supplies printer cartridges to European officesupplies distributors from its manufacturing base in Bulgaria. Prior toGreenman, he was Chief Executive of Oasis Healthcare Plc for four years duringwhich Oasis grew from a small regional business to become the leading dentalpractice owner/operator in the UK with turnover of over £70m. His previousexperience includes senior management roles at Chloride Group plc, LadbrokeGroup plc and Management Consulting Group plc. Commenting on the appointment, Michael Fort, chief executive of Synexus said : " I am delighted to welcome Malcolm to the Synexus board. He brings with himconsiderable knowledge and expertise, not only within the healthcare industrybut also particular experience of business operations within the emergingeconomies of Eastern Europe where Synexus has established a foothold and fromwhich we aim to expand rapidly. We look forward to benefiting from hiscontribution to the development and implementation of our growth strategy." Malcolm Hughes commented: "I am delighted to be joining Synexus at a time when it is seeking to build onits recent AIM flotation through expansion of its operations in the UK andinternationally. Its unique business model offers a strong proposition to globalpharmaceutical companies as they aim to develop more cost-effective methods oftrialling new drug treatments." Additional Information The following is a complete list of Mr Hughes' directorships as required underSchedule 2(g) of the AIM Rules: Current Previous in last 5 yearsGreenman Group plc Oasis Healthcare PlcGreenman UK Limited Oasis Dental Care LimitedGreenman Europe BV The Dencare Management Group LimitedK2 Supplies Limited Dencare Management LimitedPaprika Services Limited Dencare Financial Services LimitedBetforum UK Limited Dencare Developments Limited Dencare Implant Centres Limited Ora Dental Group Holdings Limited Ora Dental Group Limited Ora EBT Trustee Limited Inhoco 978 Limited Inhoco 979 Limited There is no further information required to be disclosed under Schedule 2(g) ofthe AIM Rules. For further information: Michael Fort, Chief Executive, Synexus Clinical Research PLC 01257 230 723 Zoe Biddick, Biddicks 020 7448 1000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th Apr 201212:42 pmRNSDirector/PDMR Shareholding
13th Apr 20127:00 amRNSAdditional Listing
2nd Apr 20127:00 amRNS£7million, 6 Year Contract Win
29th Mar 201210:46 amRNSAvailability of Report & Accounts
13th Mar 20129:49 amRNSHolding(s) in Company
13th Mar 20129:26 amRNSHolding(s) in Company
9th Mar 20123:56 pmRNSHolding(s) in Company
8th Mar 20125:02 pmRNSHolding(s) in Company
1st Mar 20127:01 amRNSMajor Contract Awards
1st Mar 20127:00 amRNSPreliminary Results
20th Feb 20121:35 pmRNSHolding(s) in Company
6th Feb 20127:00 amRNSNotification of Preliminary Results
1st Feb 20127:00 amRNSChange of Name of Nominated Adviser and Broker
29th Dec 201110:59 amRNSDirector/PDMR Shareholding
10th Nov 20112:41 pmRNSHolding(s) in Company
3rd Nov 20114:10 pmRNSHolding(s) in Company
1st Nov 20113:52 pmRNSDirector/PDMR Shareholding
25th Oct 20112:33 pmRNSHolding(s) in Company
11th Oct 201112:40 pmRNSHolding(s) in Company
19th Jul 20113:49 pmRNSHolding(s) in Company
18th Jul 20117:00 amRNSAcquisition of Indanet AG
8th Jun 20112:41 pmRNSHolding(s) in Company
26th May 20117:00 amRNSHolding(s) in Company
19th May 20113:28 pmRNSReplacement - Holding(s) in Company
19th May 201110:34 amRNSHolding(s) in Company
10th May 20114:14 pmRNSHolding(s) in Company
10th May 20119:53 amRNSHolding(s) in Company
5th May 20113:17 pmRNSResult of AGM
4th May 20117:00 amRNSAGM Statement
15th Apr 201110:00 amRNSHolding(s) in Company
8th Apr 20113:39 pmRNSDirector Shareholding
7th Apr 20117:00 amRNSAGM - Date Change
30th Mar 20114:35 pmRNSAvailability of Report & Accounts
8th Mar 20117:00 amRNSRe: 2009 Group Executive Shared Ownership Plan
4th Mar 20117:00 amRNSPreliminary Results
1st Feb 201111:06 amRNSNotification of Results
7th Jan 20114:02 pmRNSHolding(s) in Company
4th Jan 20117:00 amRNSAcquisition
21st Dec 201010:45 amRNSHolding(s) in Company
21st Dec 20107:00 amRNSHolding(s) in Company
16th Dec 20107:00 amRNSChange of Adviser
6th Dec 20107:00 amRNSPost Year End Trading Update
27th Jul 20107:00 amRNSInterim Results
3rd Feb 20107:00 amRNSInterim Results
21st Jan 201010:36 amRNSContract Win
15th Jan 20102:59 pmRNSREPLACEMENT: Notice of Results
15th Jan 201010:35 amRNSNotice of Results
11th Nov 200910:59 amRNSResult of AGM
5th Nov 20097:00 amRNSTrading Update
9th Sep 20097:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.